Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


07.08.2017

2 Aliment Pharmacol Ther
3 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
3 Gastroenterology
3 Gut
2 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. ALEXAKIS C, Kumar S, Saxena S, Hotopf M, et al
    Editorial: depression in the setting of inflammatory bowel disease means we have failed to provide early, effective, psychosocial care-authors' reply.
    Aliment Pharmacol Ther. 2017;46:554-555.
    PubMed     Text format    

  2. KEEFER L
    Editorial: depression in the setting of inflammatory bowel disease means we have failed to provide early, effective, psychosocial care.
    Aliment Pharmacol Ther. 2017;46:553-554.
    PubMed     Text format    


    Dig Dis Sci

  3. CARRASCO A, Fernandez-Banares F
    Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4692.
    PubMed     Text format    

  4. ALLOCCA M, Fiorino G, Danese S
    Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4693.
    PubMed     Text format    

  5. KAMAT N, Ganesh Pai C, Surulivel Rajan M, Kamath A, et al
    Cost of Illness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 1. doi: 10.1007/s10620-017-4690.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  6. VAN DEEN WK, Spiro A, Burak Ozbay A, Skup M, et al
    The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study.
    Eur J Gastroenterol Hepatol. 2017;29:331-337.
    PubMed     Text format     Abstract available


    Gastroenterology

  7. POUILLON L, Bossuyt P, Peyrin-Biroulet L
    Tofacitinib is the right OCTAVE for ulcerative colitis.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35958.
    PubMed     Text format    

  8. SURESH S, Govani SM, Waljee AK
    Ten Hove JR et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy. 2017 Feb;49(2):161-168.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35957.
    PubMed     Text format    


  9. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.
    Gastroenterology. 2017 Jul 31. pii: S0016-5085(17)35968.
    PubMed     Text format    


    Gut

  10. PANES J, Sandborn WJ, Schreiber S, Sands BE, et al
    Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
    Gut. 2017;66:1049-1059.
    PubMed     Text format     Abstract available

  11. SCHWERD T, Pandey S, Yang HT, Bagola K, et al
    Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Gut. 2017;66:1060-1073.
    PubMed     Text format     Abstract available

  12. SOKOL H, Leducq V, Aschard H, Pham HP, et al
    Fungal microbiota dysbiosis in IBD.
    Gut. 2017;66:1039-1048.
    PubMed     Text format     Abstract available


    N Engl J Med

  13. DAI C, Jiang M, Sun MJ
    Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;377:496.
    PubMed     Text format    


  14. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;377:496-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: